BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221025
DTEND;VALUE=DATE:20221028
DTSTAMP:20260516T041219
CREATED:20220708T072935Z
LAST-MODIFIED:20220708T072935Z
UID:34589-1666656000-1666915199@www.pharmajournalist.com
SUMMARY:6th Annual Gene Therapy for Rare Disorders Europe Summit 2022
DESCRIPTION:As more and more companies gear up for clinical activity and near approval decisions\, the need to have an in-depth understanding of the regulatory frameworks and how these feed into clinical development and manufacturing processes is as vital as ever. \nThis year’s summit is dedicated to gaining European regulatory clarity to progress efficient and robust gene therapies for rare diseases. By giving voice to pioneering drug developers with success stories to share\, experts in regulatory affairs\, and the regulators themselves\, this meeting is your comprehensive guide to unpicking the thorniest regulatory challenges. \nAcross three carefully curated days\, this streamlined one-track summit will unite key gene therapy leaders from large pharma to ground-breaking biotech\, academics to exciting service providers\, all with the purpose of paving a way forward to successfully launch gene therapy products in Europe. \nTo know more visit: https://bit.ly/3ysiVts
URL:https://www.pharmajournalist.com/event/6th-annual-gene-therapy-for-rare-disorders-europe-summit-2022/
LOCATION:London Marriott Hotel Regents Park\, 128 King Henry’s Road\, London\, NW3 3ST\, United Kingdom
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221025
DTEND;VALUE=DATE:20221028
DTSTAMP:20260516T041219
CREATED:20220801T092348Z
LAST-MODIFIED:20220801T092348Z
UID:34838-1666656000-1666915199@www.pharmajournalist.com
SUMMARY:7th Annual Computational Drug Development (CDD) for Biologics Summit
DESCRIPTION:Returning to Boston this October\, the 7th Annual Computational Drug Development (CDD) for Biologics Summit will continue to build on the reputation of past meetings while diving into the latest innovations in the industry. This year’s summit will highlight methods and best-practices to extrapolating data & leveraging deep learning for novel\, complex biologics pipeline progression.  \nAcross 3 days\, we will unite leading experts including AbbVie\, GSK\, Amgen\, Genentech\, Takeda & many more to: \n\nOvercome data availability and collection challenges to support machine learning and in silico drug discovery and development for biologics\nRefine high throughput screening methods for novel antibody candidates to shorten your drug development cycles\nAdvance the next generation of computational biology in designing complex antibodies – including multifunctional\, multi-specific antibodies\nEmpower the predictability of protein structures and protein-protein interactions for better drug development\nOptimize your development cycle and decision making using computational data\n\nFind out more – https://ter.li/ec2qbx
URL:https://www.pharmajournalist.com/event/7th-annual-computational-drug-development-cdd-for-biologics-summit/
LOCATION:Boston Marriott Burlington\, One Burlington Mall Road\, Burlington\, MA\, 01803\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221026
DTEND;VALUE=DATE:20221028
DTSTAMP:20260516T041219
CREATED:20220812T122604Z
LAST-MODIFIED:20220812T122604Z
UID:34912-1666742400-1666915199@www.pharmajournalist.com
SUMMARY:Protein Engineering Biocatalysis Congress
DESCRIPTION:The Protein Engineering Biocatalysis Congress is the unique meeting point of industry\, academia and service providers which will enable protein engineering and biocatalysis enthusiasts to industrialize sustainable enzyme products and increase product efficiency globally. \nThis event will highlight case studies on scaling up protein engineering technologies for commercial scale. It is your opportunity to analyze developments in protein engineering for biocatalysis to establish sustainable\, scalable and cost-efficient API manufacturing. \nTo know more visit: www.proteinengineeringglobal.com
URL:https://www.pharmajournalist.com/event/protein-engineering-biocatalysis-congress/
LOCATION:Philadelphia\, USA (venue TBC)
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
END:VCALENDAR